Literature DB >> 15331059

The histologic spectrum of nonalcoholic fatty liver disease.

Melissa J Contos1, Jayanta Choudhury, A Scott Mills, Arun J Sanyal.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) represents a range of histologic lesions in the liver that occur in individuals who do not consume alcohol in quantities that generally are considered to be harmful. The histologic spectrum of NAFLD includes isolated predominantly macrovesicular steatosis alone at one end and steatohepatitis at the other. Nonalcoholic steatohepatitis can progress to cirrhosis and now also is considered to be a precursor of cryptogenic cirrhosis. This article provides an understanding of the histologic features of NAFLD and the potential pitfalls in the histologic assessment of this condition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331059     DOI: 10.1016/j.cld.2004.04.013

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  14 in total

Review 1.  Genetic and epigenetic mechanisms of NASH.

Authors:  Mohammed Eslam; Jacob George
Journal:  Hepatol Int       Date:  2015-12-18       Impact factor: 6.047

2.  PTEN in liver diseases and cancer.

Authors:  Marion Peyrou; Lucie Bourgoin; Michelangelo Foti
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

3.  Hepatocellular ballooning in NASH.

Authors:  Stephen Caldwell; Yoshihiro Ikura; Daniela Dias; Kosuke Isomoto; Akito Yabu; Christopher Moskaluk; Patcharin Pramoonjago; Winsor Simmons; Harriet Scruggs; Nicholas Rosenbaum; Timothy Wilkinson; Patsy Toms; Curtis K Argo; Abdullah M S Al-Osaimi; Jan A Redick
Journal:  J Hepatol       Date:  2010-06-25       Impact factor: 25.083

4.  Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea.

Authors:  Young Eun Chon; Kyu Sik Jung; Kwang Joon Kim; Dong Jin Joo; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Seung Up Kim
Journal:  Dig Dis Sci       Date:  2014-08-14       Impact factor: 3.199

5.  Saturated free fatty acids induce cholangiocyte lipoapoptosis.

Authors:  Sathish Kumar Natarajan; Sally A Ingham; Ashley M Mohr; Cody J Wehrkamp; Anuttoma Ray; Sohini Roy; Sophie C Cazanave; Mary Anne Phillippi; Justin L Mott
Journal:  Hepatology       Date:  2014-06-20       Impact factor: 17.425

6.  Effects of increased dietary cholesterol with carbohydrate restriction on hepatic lipid metabolism in Guinea pigs.

Authors:  Ryan deOgburn; Jose O Leite; Joseph Ratliff; Jeff S Volek; Mary M McGrane; Maria Luz Fernandez
Journal:  Comp Med       Date:  2012-04       Impact factor: 0.982

7.  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Amy G Shah; Alison Lydecker; Karen Murray; Brent N Tetri; Melissa J Contos; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-10       Impact factor: 11.382

8.  PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.

Authors:  Marion Peyrou; Pierluigi Ramadori; Lucie Bourgoin; Michelangelo Foti
Journal:  PPAR Res       Date:  2012-09-13       Impact factor: 4.964

9.  Silymarin induces insulin resistance through an increase of phosphatase and tensin homolog in Wistar rats.

Authors:  Kai-Chun Cheng; Akihiro Asakawa; Ying-Xiao Li; Hsien-Hui Chung; Haruka Amitani; Takatoshi Ueki; Juei-Tang Cheng; Akio Inui
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

10.  Pinus densiflora Sieb. et Zucc. alleviates lipogenesis and oxidative stress during oleic acid-induced steatosis in HepG2 cells.

Authors:  Yu-Jin Hwang; Hae-Ri Wi; Haeng-Ran Kim; Kye Won Park; Kyung-A Hwang
Journal:  Nutrients       Date:  2014-07-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.